Literature DB >> 3032329

Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Clinical, pathological and immunological features.

P A McCombe, J G McLeod, J D Pollard, Y P Guo, T J Ingall.   

Abstract

The clinical features and pathological findings in the sural nerves are described of 7 patients with peripheral neuropathy; in 4 cases the criteria for diagnosis of systemic lupus erythematosus (SLE) were satisfied and in 3 other cases there was serological evidence of an undifferentiated connective tissue disease, most probably SLE. The peripheral neuropathy was of a chronic sensorimotor type with predominantly sensory features and gradual onset. In 2 cases the presentation was asymmetric. One patient had autonomic dysfunction. The pathological findings in the biopsied sural nerves were those of axonal degeneration and vasculitis. In 6 nerves there was increased expression of Class II (Ia) antigen within the nerve fascicle, perineurium and within endothelial cells.

Entities:  

Mesh:

Year:  1987        PMID: 3032329     DOI: 10.1093/brain/110.2.533

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  7 in total

1.  HLA-DR expression in peripheral neuropathies: the role of Schwann cells, resident and hematogenous macrophages, and endoneurial fibroblasts.

Authors:  C Sommer; J M Schröder
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

2.  Treatment of Raynaud's phenomenon with triiodothyronine corrects co-existent autonomic dysfunction: preliminary findings.

Authors:  R F Gledhill; P H Dessein; C A Van der Merwe
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

3.  Lack of correlation between anticardiolipin antibodies and peripheral autonomic nerve involvement in systemic lupus erythematosus.

Authors:  M Magarò; L Mirone; L Altomonte; A Zoli; S Angelosante
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

Review 4.  Peripheral nerve disease secondary to systemic conditions in children.

Authors:  Jo M Wilmshurst; Robert A Ouvrier; Monique M Ryan
Journal:  Ther Adv Neurol Disord       Date:  2019-08-12       Impact factor: 6.570

5.  Therapy for vasculitic neuropathies.

Authors:  Kenneth C Gorson
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

6.  The association among antioxidant enzymes, autoantibodies, and disease severity score in systemic lupus erythematosus: comparison of neuropsychiatric and nonneuropsychiatric groups.

Authors:  Yu-Jih Su; Tien-Tsai Cheng; Chung-Jen Chen; Wen-Chan Chiu; Wen-Neng Chang; Nai-Wen Tsai; Chia-Te Kung; Wei-Che Lin; Chih-Cheng Huang; Ya-Ting Chang; Chih-Min Su; Yi-Fang Chiang; Ben-Chung Cheng; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

7.  The introspection on the diagnosis and treatment process of a case of Guillain-Barré syndrome (GBS) attributed to systemic lupus erythematosus (SLE): A case report.

Authors:  Nan Zhang; Jie Cao; Meng Zhao; Li Sun
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.